SWAV stock results show that ShockWave Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.More From InvestorPlace The #1 AI Investment Might Be ...
For the quarter ended March 2024, Shockwave Medical (SWAV) reported revenue of $218.81 million, up 35.8% over the same period last year. EPS came in at $1.44, compared to $1.03 in the year-ago quarter ...
SANTA CLARA, Calif. (AP) — SANTA CLARA, Calif. (AP) — Shockwave Medical Inc. (SWAV) on Monday reported first-quarter profit of $55.3 million. The Santa Clara, California-based company said it had ...
LYNCHBURG, Va. (WDBJ) - A lengthy law enforcement effort called Operation Shockwave, conducted by several law enforcement agencies over the past year, has led to the prosecution of 47 defendants ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Extracorporeal shockwave therapy may be effective for intermittent lower limb claudication in peripheral artery disease ...
Shockwave Medical (SWAV) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.03 per share a year ago. These ...
(Reuters) -Johnson & Johnson on Friday agreed to buy Shockwave Medical for $12.5 billion, in a deal that would help broaden its portfolio of medical devices used in treating heart diseases. The ...
Some results have been hidden because they may be inaccessible to you